title: Reforming the EU environment for clinical trials: what are the challenges?
authors.affiliation: Policy Advisor, FEAM, Palais des Académies, Rue Ducale 1, 1000 Brussels, Belgium. laurence.legros@feam.eu.com.
authors.forename: R
authors.initials: R
authors.lastname: Fears
authors.forename: H E
authors.initials: HE
authors.lastname: Blum
authors.forename: D
authors.initials: D
authors.lastname: Kelleher
authors.forename: F
authors.initials: F
authors.lastname: Meunier
authors.forename: R
authors.initials: R
authors.lastname: Souhami
mesh_terms: D002986:Clinical Trials as Topic / Q000191:economics / Q000331:legislation & jurisprudence* / Q000592:standards; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D005062:European Union; D006801:Humans; D011785:Quality Assurance, Health Care / Q000331:legislation & jurisprudence / Q000592:standards*